Is ESWT Better in Plantar Fasciitis Treatment?

Harran University

Status: Completed

Conditions: Plantar Fascitis

Treatments: Drug: Corticosteroid injection; Device: Kinesiotaping; Device: extracorporeal Shock wave therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT05647291

HRU/21.17.30

Details and patient eligibility

About

It was aimed to compare the pain and functional results of ESWT, kinesiotherapy and corticosteroid injection in patients with treatment-resistant plantar fasciitis.

Full description

The groups were randomized in patients with chronic plantar fasciitis who did not benefit from conservative treatment. A questionnaire study was conducted at the first visit, sixth week, third month, and sixth month. Visual analog scale (VAS) and The American Orthopedic Foot and Ankle Society (AOFAS) score were applied as a questionnaire at each control visit of the patients.

Enrollment: 90 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• previously diagnosed with PF,
• did not benefit from conservative treatment for at least six months,
• did not use anticoagulants,
• did not have bleeding disorders,
• did not have a psychiatric disease

Exclusion criteria

• previous ESWT or CI treatment
• obesity,
• seronegative spondyloarthropathy,
• tarsal tunnel syndrome,
• peripheral neuropathy,
• foot-ankle deformity (pes cavus, pes planus, etc.),
• history of mass around foot and ankle,
• previous foot or ankle surgery
• degenerative arthritis around this region

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Factorial Assignment

Masking: Double Blind

---

90 participants in 3 patient groups

extracorporeal Shock wave therapy (ESWT)

Experimental group

Description:

ESWT was performed by the same physician. The applicator was placed at the point of maximum sensitivity. Two thousand pulses with a frequency of 6 Hz and a pressure of 3 bar were applied to patients with an Auto Wave 695 (Mettler electronics, USA) brand device. Patients underwent two sessions of ESWT per week for two weeks, adding up to a total of 4 sessions. Local or regional anesthesia was not administered to any patient during ESWT.

Treatment:

Device: extracorporeal Shock wave therapy

Kinesiotaping

Active Comparator group

Description:

Kinesio tape (KinesioTex, KinesioTaping, US) was applied to the relevant extremity of the patient by the physical therapy and rehabilitation physician once a week, three times in total. During KT, the patient was positioned with the knee and ankle joints in the neutral position. The first strip was adhered along the plantar fascia from the calcaneus to the toes using maximum stretch. The other four strips of tape were attached medially and laterally to support the medial longitudinal arch with a 45° inclination. While maximum stretching was applied to the middle 1/3 of all bands, no stretching was applied to the ends.

Treatment:

Device: Kinesiotaping

Corticosteroid injection

Active Comparator group

Description:

In the CI group, 40mg/1ml methylprednisolone was applied from the inferior-medial side of the heel to the most sensitive area of the calcaneus medial tubercle of the plantar fascia. The same physician performed a total of two sessions once a week.

Treatment:

Drug: Corticosteroid injection